Amiodarone-induced diffuse alveolar haemorrhage: a rare but potentially life-threatening complication of a commonly prescribed medication
| Autor: | Jamaluddin Saeed, Hafez Mohammad Ammar Abdullah, Qazi Ahmed Waqas, Uzma Ikhtiar Khan |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_treatment
Amiodarone Hemorrhage 030204 cardiovascular system & hematology Antiarrhythmic agent Interstitial pneumonitis Diagnosis Differential 03 medical and health sciences 0302 clinical medicine medicine Humans Aged medicine.diagnostic_test business.industry General Medicine Radiography Clinical Practice Respiratory Medicine Bronchoalveolar lavage 030228 respiratory system Anesthesia Female Steroids Lung Diseases Interstitial Complication business Anti-Arrhythmia Agents medicine.drug |
| Zdroj: | BMJ Case Reports. 12:e232149 |
| ISSN: | 1757-790X |
| DOI: | 10.1136/bcr-2019-232149 |
| Popis: | Amiodarone is an antiarrhythmic agent that is used commonly in clinical practice. It is associated with many side effects, the most common being pulmonary manifestations. Interstitial pneumonitis is one of the most common complications, however rarely amiodarone can cause diffuse alveolar haemorrhage (DAH) too. We describe the case of a 73-year-old woman who presented with shortness of breath and haemoptysis 4 days after starting amiodarone. She was diagnosed with amiodarone-induced DAH based on imaging and bronchoalveolar lavage. She was treated with intravenous and then oral steroids, and amiodarone was discontinued. The patient made a significant clinical and radiological recovery. She was discharged 10 days after her presentation. This case highlights a rare but potentially life-threatening complication of a commonly used medication. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|